<DOC>
	<DOCNO>NCT00157651</DOCNO>
	<brief_summary>This study examine whether low intensity , dose adjust warfarin prolongs time mechanical failure hemodialysis catheter without result unacceptable rate bleeding .</brief_summary>
	<brief_title>Access II - Trial Warfarin Prevent Malfunction Haemodialysis Catheters</brief_title>
	<detailed_description>Patients end-stage renal disease receive initiate hemodialysis randomize receive either adjust dose warfarin achieve INR 1.5-1.9 adjust dose placebo within 72 hour hemodialysis catheter placement . The primary outcome mechanical failure catheter , outline .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Newly place doublelumen hemodialysis catheter Major bleed within last 3 month Platelet count le 50 x 10 9/L current coagulopathy ( recent INR &gt; 1.5 , due warfarin ) Active peptic ulcer disease Anticipated need invasive intervention within next 2 week Taking warfarin indication access prophylaxis Allergic , intolerant , warfarin Pregnant Woman childbearing age agree use adequate method birth control duration study Catheter likely need 2 week less Patient previously take part study Patient know aortic aneurysm 6cm great Patients nephrologist refused consent Patient refuse consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>end stage renal disease</keyword>
	<keyword>thrombosis</keyword>
	<keyword>bleeding</keyword>
</DOC>